BI-1910
BI-1910 is a human monoclonal antibody (mAb) targeting TNFRSF1B. BI-1910 enhances T cell activation and induces CD8 T cell-dependent anti-tumor effects. BI-1910 can be used in solid tumors research. Recommended isotype control: Human IgG1 lambda, Isotype Control.
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[BI-1910]
References & Citations
[1]Martensson L, et al. 1368 preclinical development of an agonistic anti-TNFR2 antibody (BI-1910) for cancer immunotherapy[J]. 2023.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
